𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sentinel lymph node mapping opens a new perspective in the surgical management of early-stage breast cancer: A combined approach with vital blue dye lymphatic mapping and radioguided surgery

✍ Scribed by Giuseppe Canavese; Marco Gipponi; Alessandra Catturich; Carmine Di Somma; Carlo Vecchio; Francesco Rosato; Daniela Tomei; Ferdinando Cafiero; Luciano Moresco; Guido Nicolò; Franca Carli; Giuseppe Villa; Ferdinando Buffoni; Fausto Badellino


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
45 KB
Volume
15
Category
Article
ISSN
8756-0437

No coin nor oath required. For personal study only.

✦ Synopsis


Recent studies have demonstrated the possibility of identifying the sentinel lymph node (sN) as a reliable predictor of axillary lymph node status in both cutaneous melanoma and breast cancer. However, some important issues need further definition: (1) optimization of the technique for intraoperative detection of the sN; (2) predictive value of the sN as regards axillary lymph node status, and (3) reliability of intraoperative histology of the sN. We report our experience in sN mapping in patients with Stage I-II breast cancer, with the aim of assessing:

(1) the feasibility of lymphatic mapping with a combined approach (vital blue dye lymphatic mapping and radioguided surgery); (2) the agreement of the intraoperative histologic examination of the sN, by means of hematoxylin and eosin staining with final histology, and (3) the accuracy of sN histology as a predictor of axillary lymph node status. Semin.


📜 SIMILAR VOLUMES


Sentinel lymph node mapping in early-sta
✍ Giuseppe Canavese; Marco Gipponi; Alessandra Catturich; Carmine Di Somma; Carlo 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 1 views

lymphadenectomies were performed because 1 patient had bilateral breast cancer; the sN was identified in 45/49 lymphadenectomies (92%). The sN was intraoperatively negative at frozen-section examination in 33 cases, and final histology confirmed the absence of metastases in 31/33 cases (94%), wherea